1. Home
  2. GUNN vs PGEN Comparison

GUNN vs PGEN Comparison

Compare GUNN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

GUNN

Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

N/A

Current Price

$5.27

Market Cap

2.7B

Sector

N/A

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GUNN
PGEN
Founded
N/A
1998
Country
United States
United States
Employees
106
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
GUNN
PGEN
Price
$5.27
$4.21
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $13.67
AVG Volume (30 Days)
69.5K
★ 6.8M
Earning Date
03-24-2027
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.12
Revenue
N/A
★ $230,981,000.00
Revenue This Year
$593.30
$2,380.31
Revenue Next Year
$10.53
$84.01
P/E Ratio
★ N/A
$34.63
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$3.04
52 Week High
$9.16
$8.98

Technical Indicators

Market Signals
Indicator
GUNN
PGEN
Relative Strength Index (RSI) 21.80 31.74
Support Level N/A $3.89
Resistance Level $8.91 $4.41
Average True Range (ATR) 0.71 0.36
MACD -0.29 -0.01
Stochastic Oscillator 3.09 16.78

Price Performance

Historical Comparison
GUNN
PGEN

About GUNN Gunnison Copper Corp. American Depositary Shares (each representing thirty (30) Common Shares)

Gunnison Copper Corp is engaged in the acquisition, exploration, and development of copper mineral properties and the construction and operation of copper mines in Arizona, USA. The company is focused on the development of the Gunnison Copper Project, which is designed to be a large-scale open pit operation producing finished copper cathodes. The company operates in two reportable operating segments in the United States: Gunnison and Johnson Camp Mine.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: